Pages that link to "Q40604961"

The following pages link to Brain monoamines and parkinsonism (Q40604961):

Displaying 24 items.

• Non-Linear EMG Parameters for Differential and Early Diagnostics of Parkinson's Disease (Q30449049) (← links)
• Maladaptive striatal plasticity in L-DOPA-induced dyskinesia (Q34094008) (← links)
• Noradrenaline and Parkinson's disease (Q35013240) (← links)
• Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates (Q35690133) (← links)
• Retracted: Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice (Q35893872) (← links)
• Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice (Q35951218) (← links)
• Depression of Serotonin Synaptic Transmission by the Dopamine Precursor L-DOPA (Q35952108) (← links)
• Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function (Q36936920) (← links)
• PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. (Q36942673) (← links)
• A scan without evidence is not evidence of absence: Scans without evidence of dopaminergic deficit in a symptomatic leucine-rich repeat kinase 2 mutation carrier. (Q36972794) (← links)
• 14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria (Q37194162) (← links)
• AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters (Q37275446) (← links)
• Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease. (Q37574459) (← links)
• Adaptation and sensitization to proteotoxic stress. (Q37651678) (← links)
• Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease (Q38598375) (← links)
• Non-human primate models of PD to test novel therapies (Q39229450) (← links)
• Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson's disease (Q42293865) (← links)
• Nitric Oxide-Soluble Guanylyl Cyclase-Cyclic GMP Signaling in the Striatum: New Targets for the Treatment of Parkinson's Disease? (Q42785592) (← links)
• Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats. (Q46153193) (← links)
• Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis. (Q46361347) (← links)
• Dopamine and Acetylcholine, a Circuit Point of View in Parkinson's Disease (Q47178205) (← links)
• Relationship between CSF hypocretin levels and hypocretin neuronal loss (Q48602913) (← links)
• Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis (Q51930607) (← links)
• A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease (Q64767865) (← links)